Fabrice Plasson
Chairman bei Amoeba US Corp.
Profil
Fabrice Plasson founded Amoéba SA in 2010 and served as President & Chief Executive Officer until 2015.
He is also the founder of Eurofins DiscoverX Corp., Inc., EUROFINS DISCOVERX PRODUCTS FRANCE.
Currently, he serves as Chairman at Amoeba US Corp.
and Entreprise Amoeba Canada, Inc. He previously worked as a Principal at Whatman Ltd.
Mr. Plasson holds an MBA from EM Lyon Business School and a graduate degree from Université Joseph Fourier.
Aktive Positionen von Fabrice Plasson
Unternehmen | Position | Beginn |
---|---|---|
Amoeba US Corp. | Chairman | - |
Entreprise Amoeba Canada, Inc. | Chairman | - |
Ehemalige bekannte Positionen von Fabrice Plasson
Unternehmen | Position | Ende |
---|---|---|
AMOÉBA | Chief Executive Officer | 14.12.2023 |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Chief Executive Officer | - |
Whatman Ltd. | Corporate Officer/Principal | - |
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Founder | - |
Ausbildung von Fabrice Plasson
EM Lyon Business School | Masters Business Admin |
Université Joseph Fourier | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMOÉBA | Consumer Non-Durables |
Private Unternehmen | 5 |
---|---|
Eurofins DiscoverX Corp., Inc.
Eurofins DiscoverX Corp., Inc. BiotechnologyHealth Technology Eurofins DiscoverX Corp. develops, manufactures, and commercializes reagents and complete cell-based assay kits and provides profiling and screening services as well as other turnkey solutions for the drug discovery, screening, and life science markets. Its products include cell lines, target engagement assays, biochemical assays, detection reagents, cell culture kits, reagents, and consumables, ligands, and inhibitors, and retroviruses and cloning vectors. The company was founded by Pyare Khanna and Fabrice Plasson in January 2000 and is headquartered in Fremont, CA. | Health Technology |
Whatman Ltd. | |
Amoeba US Corp. | |
Entreprise Amoeba Canada, Inc. | |
EUROFINS DISCOVERX PRODUCTS FRANCE
EUROFINS DISCOVERX PRODUCTS FRANCE Miscellaneous Commercial ServicesCommercial Services EUROFINS DISCOVERX PRODUCTS FRANCE provides functional cell-based assays to analyze signaling, dimerization, internalization, and clustering/crosslinking of checkpoint receptors. The private company is based in Celle-L Evescault, France. The French company also offers GPCR and ion channel membrane preps for determining ligand binding affinities and performing functional studies to evaluate GPCR activity in response to a ligand or therapeutic. Additionally, they provide pharmacologically and functionally validated ion channel cell lines, voltage-gated, ligand-gated and other ion channels products for discovery and safety applications. The company was founded by Fabrice Plasson. | Commercial Services |